Scott Gottlieb is poised to become chief of the U.S. Food and Drug Administration, neuroscience research has blossomed over the past decade, and new grants support adults with autism.

The Chan Zuckerberg Initiative has pledged to provide financial support for bioRxiv, a website where researchers can share manuscripts before peer review.

Children with chronic conditions are especially vulnerable to health insurance changes, as they often rely on specialists and medications that may not be covered if they switch plans.

A massive new analysis drops the ratio of boys to girls who qualify for an autism diagnosis to about 3-to-1.

Eight pharmaceutical companies more than doubled their lobbying spending in the first three months of 2017.

Understanding autism features in children who were deprived of social contact as infants could offer clues to the condition.

Tens of thousands of people protested the U.S. administration’s anti-science policies on Saturday.

Facing acute risks to their businesses from Washington policymakers, health companies spent more than $2 million to buy access to the incoming Trump administration via candlelight dinners, black-tie balls and other inauguration events.

The March for Science is finally here, the scientific workforce is aging at an alarming rate, and a pint-size podcaster tackles serious science.

Both the Pharmaceutical Research and Manufacturers of America and the nonprofit group have gone to great lengths to show that drugmakers are not driving what they describe as a “grass-roots” effort to fight imports.